Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.30) b...
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingIRVINE, CA, and HERSTAL, BELGIUM – March 12, ...
MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday.
Piper Sandler analyst Jason Bednar maintains MDxHealth (NASDAQ:MDXH) with a Overweight and raises the price target from $6 t...
BTIG analyst Mark Massaro maintains MDxHealth (NASDAQ:MDXH) with a Buy and raises the price target from $7 to $8.
MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.390) per share which missed the analyst consensus estimate of $(0.150)...
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as fol...
